Lexaria Bioscience Corp. Common Stock (LEXX) Stock Price, Quote & AI Analysis
Live LEXX stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for Lexaria Bioscience Corp. Common Stock.
TradeVae provides AI-driven analysis and real-time market intelligence for Lexaria Bioscience Corp. Common Stock (LEXX), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.
AI Analysis
Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.
Generating AI analysis...
Lexaria Bioscience Corp. Common Stock's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.
Lexaria Bioscience Corp. Common Stock Overview
Company information
Company Overview
Lexaria Bioscience Corp. is a biotechnology company, which engages in the provision of active pharmaceutical ingredients through its DehydraTECH drug delivery technology. It operates through the IP licensing segment which generates revenue from customers by licensing its proprietary DehydraTECH technology. The company was founded on December 9, 2004 and is headquartered in Kelowna, Canada.
Company Details
Technical Indicators
Key technical analysis metrics and signals
Loading technical indicators...
Valuation Metrics
Key valuation ratios and comparisons
Loading valuation metrics...
Lexaria Bioscience Corp. Common Stock Earnings & Financial Statements
Earnings Calendar
Upcoming earnings dates and historical surprises
Loading earnings calendar...
Financial Statements
Income statements, balance sheets, and cash flow
Loading income statements...
Loading balance sheets...
Loading cash flow statements...